BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16130598)

  • 1. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
    Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
    Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of proangiogenic cytokines in children with lymphomas.
    Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
    Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of bFGF and VEGF in acute leukemia and its effects on HL-60 cell growth].
    Zhang WP; Chun XQ; Zhang YQ; Liang R; Li YH; Gao GX; Zhu HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):91-4. PubMed ID: 15748443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
    Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
    Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
    Wierzbowska A; Robak T; Krawczyńska A; Pluta A; Wrzesień-Kuś A; Cebula B; Robak E; Smolewski P
    Ann Hematol; 2008 Feb; 87(2):97-106. PubMed ID: 17849117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of vascular endothelial growth factor and basic fibroblast growth factor in lymphoproliferative disorders.
    Smolej L; Andrýs C; Maisnar V; Pour L; Malý J
    Acta Medica (Hradec Kralove); 2005; 48(1):57-8. PubMed ID: 16080387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
    Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T
    Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
    Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
    Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
    Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
    Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum level of angiogenesis-related cytokins in patients with myelodysplastic syndrome].
    Zhao MQ; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):519-22. PubMed ID: 17605857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.
    Vizio B; Novarino A; Giacobino A; Cristiano C; Prati A; Brondino G; Ciuffreda L; Bellone G
    Cancer Sci; 2010 Nov; 101(11):2448-54. PubMed ID: 20950371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proangiogenic cytokines vascular-endothelial growth factor and basic fibroblst growth factor in childhood lymphadenopathy.
    Mizia-Malarz A; Sobol G; Musioł K; Janowska J; Zahorska-Markiewicz B; Wos H
    Pediatr Hematol Oncol; 2010 Aug; 27(5):393-404. PubMed ID: 20615068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.
    Dmoszyńska A; Bojarska-Junak A; Domański D; Roliński J; Hus M; Soroka-Wojtaszko M
    Leuk Lymphoma; 2002 Feb; 43(2):401-6. PubMed ID: 11999576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.